SubsidieMeesters logoSubsidieMeesters
ProjectenRegelingenAnalyses

DeCiphering Systemic Diurnal MetabOlism and EnDocrinE Signaling in HEART Failure

CODE-HEART aims to uncover how heart failure alters systemic metabolic rhythms through interorgan communication, enhancing understanding of its complex multiorgan nature.

Subsidie
€ 1.721.063
2025

Projectdetails

Introduction

Heart failure (HF), the ultimate outcome of many cardiovascular pathologies, imposes a significant global health and economic burden while remaining associated with high mortality rates. There is therefore an urgent need for innovative approaches to comprehensively understand and treat HF.

Research Focus

Most HF research has thus far focused on the pathophysiology of the heart, only partially covering the role of non-cardiac organs, despite HF being a complex multiorgan syndrome. The extent to which extra-cardiac organs, particularly those playing a key role in metabolism control, contribute to HF remains largely unknown.

Project Aim

CODE-HEART aims to bridge this knowledge gap by focusing on metabolic interorgan mechanisms of disease. Our metabolism is temporally coordinated across tissues by the circadian clock system, which orchestrates a myriad of physiological and metabolic processes.

Preliminary Findings

My recent work has highlighted the significance of peripheral tissue-tissue communication for daily metabolic homeostasis. Notably, my preliminary findings suggest that when the heart is under stress, systemic glucose and lipid diurnal metabolism is rewired.

Hypothesis

In this project, I will test the hypothesis that the failing heart can alter systemic diurnal metabolic rhythms via the release of specific cardiac-secreted factors.

Methodology

To do so, I will:

  1. Determine the impact of HF on systemic metabolic rhythms and on the diurnal transcriptional landscape of liver, skeletal muscle, and white adipose tissue.
  2. Use specific knockout animal models to investigate the consequences of systemic metabolic rewiring on cardiac function in HF.
  3. Pinpoint the metabolic communication network between the heart, liver, and other metabolic tissues by labeling cardiomyocyte-specific secreted proteins and screening their functions in vitro and in vivo.

Conclusion

In summary, CODE-HEART will significantly advance our understanding of the metabolic and molecular adaptation occurring in HF.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.721.063
Totale projectbegroting€ 1.721.063

Tijdlijn

Startdatum1-1-2025
Einddatum31-12-2029
Subsidiejaar2025

Partners & Locaties

Projectpartners

  • HUMANITAS UNIVERSITYpenvoerder

Land(en)

Italy

Inhoudsopgave

European Research Council

Financiering tot €10 miljoen voor baanbrekend frontier-onderzoek via ERC-grants (Starting, Consolidator, Advanced, Synergy, Proof of Concept).

Bekijk regeling

Vergelijkbare projecten binnen European Research Council

ProjectRegelingBedragJaarActie

Linking Ketone Metabolism and Signaling in Heart Failure with Preserved Ejection Fraction

This project aims to explore the dual role of ketones in heart failure with preserved ejection fraction, investigating their function as energy sources and protein modifiers to enhance cardiomyocyte health.

ERC Starting...€ 1.809.140
2023
Details

Dynamic engIneered heart tiSsue to Study intEr-individual susCeptibily and improve Treatment of Heart Failure

DISSECT-HF aims to engineer heart tissue from patient-specific stem cells to uncover common mechanisms of heart failure across different etiologies and improve treatment strategies.

ERC Consolid...€ 1.998.775
2022
Details

Circadian Control of Systemic Metabolism in Physiology and Type 2 Diabetes

This project aims to uncover how synchronizing energetic stressors with circadian rhythms can improve metabolism and inform new treatments for type 2 diabetes.

ERC Advanced...€ 2.500.000
2024
Details

Advanced human models of the heart to understand cardiovascular disease

Heart2Beat aims to develop innovative 3D human cardiac models using microfluidic technology to enhance understanding and treatment of cardiovascular diseases through personalized medicine.

ERC Advanced...€ 2.500.000
2023
Details

Circular RNAs to reverse pathological remodelling of the injured heart

REVERSE aims to identify and validate therapeutic circular RNAs to target cardiac remodelling in chemotherapy-induced cardiotoxicity and SARS-CoV-2 infection, addressing unmet treatment needs.

ERC Advanced...€ 2.499.375
2022
Details
ERC Starting...

Linking Ketone Metabolism and Signaling in Heart Failure with Preserved Ejection Fraction

This project aims to explore the dual role of ketones in heart failure with preserved ejection fraction, investigating their function as energy sources and protein modifiers to enhance cardiomyocyte health.

ERC Starting Grant
€ 1.809.140
2023
Details
ERC Consolid...

Dynamic engIneered heart tiSsue to Study intEr-individual susCeptibily and improve Treatment of Heart Failure

DISSECT-HF aims to engineer heart tissue from patient-specific stem cells to uncover common mechanisms of heart failure across different etiologies and improve treatment strategies.

ERC Consolidator Grant
€ 1.998.775
2022
Details
ERC Advanced...

Circadian Control of Systemic Metabolism in Physiology and Type 2 Diabetes

This project aims to uncover how synchronizing energetic stressors with circadian rhythms can improve metabolism and inform new treatments for type 2 diabetes.

ERC Advanced Grant
€ 2.500.000
2024
Details
ERC Advanced...

Advanced human models of the heart to understand cardiovascular disease

Heart2Beat aims to develop innovative 3D human cardiac models using microfluidic technology to enhance understanding and treatment of cardiovascular diseases through personalized medicine.

ERC Advanced Grant
€ 2.500.000
2023
Details
ERC Advanced...

Circular RNAs to reverse pathological remodelling of the injured heart

REVERSE aims to identify and validate therapeutic circular RNAs to target cardiac remodelling in chemotherapy-induced cardiotoxicity and SARS-CoV-2 infection, addressing unmet treatment needs.

ERC Advanced Grant
€ 2.499.375
2022
Details

Vergelijkbare projecten uit andere regelingen

ProjectRegelingBedragJaarActie

Boost of Diuretics

Het project ontwikkelt een goedkope en effectieve methode voor thuismonitoring van hart- en longfalen, gericht op het tijdig signaleren van verslechtering om zorglasten te verlichten.

Mkb-innovati...€ 20.000
2020
Details

Comprehensive Analysis of RBM20-induced Dilated Cardiomyopathies using Omics Approaches and Repair Interventions

CARDIOREPAIR aims to identify and therapeutically target RBM20 mutations in dilated cardiomyopathy using high-throughput genomics and bioengineering to improve heart health outcomes.

EIC Pathfinder€ 4.349.410
2023
Details

Engineering a living human Mini-heart and a swimming Bio-robot

The project aims to develop advanced in vitro human cardiac models, including a vascularized mini-heart and a bio-robot, to better assess cardiotoxicity and improve understanding of cardiovascular disease.

EIC Pathfinder€ 4.475.946
2022
Details

Enabling advances in diagnosis, patient stratification and treatment for dilated cardiomyopathy patients and families.

The DCM-NEXT consortium aims to enhance genetic testing and develop novel therapies for dilated cardiomyopathy by leveraging extensive clinical and omics data from 11,750 patients.

EIC Pathfinder€ 4.137.668
2023
Details
Mkb-innovati...

Boost of Diuretics

Het project ontwikkelt een goedkope en effectieve methode voor thuismonitoring van hart- en longfalen, gericht op het tijdig signaleren van verslechtering om zorglasten te verlichten.

Mkb-innovatiestimulering Topsectoren Haalbaarheid
€ 20.000
2020
Details
EIC Pathfinder

Comprehensive Analysis of RBM20-induced Dilated Cardiomyopathies using Omics Approaches and Repair Interventions

CARDIOREPAIR aims to identify and therapeutically target RBM20 mutations in dilated cardiomyopathy using high-throughput genomics and bioengineering to improve heart health outcomes.

EIC Pathfinder
€ 4.349.410
2023
Details
EIC Pathfinder

Engineering a living human Mini-heart and a swimming Bio-robot

The project aims to develop advanced in vitro human cardiac models, including a vascularized mini-heart and a bio-robot, to better assess cardiotoxicity and improve understanding of cardiovascular disease.

EIC Pathfinder
€ 4.475.946
2022
Details
EIC Pathfinder

Enabling advances in diagnosis, patient stratification and treatment for dilated cardiomyopathy patients and families.

The DCM-NEXT consortium aims to enhance genetic testing and develop novel therapies for dilated cardiomyopathy by leveraging extensive clinical and omics data from 11,750 patients.

EIC Pathfinder
€ 4.137.668
2023
Details

SubsidieMeesters logoSubsidieMeesters

Vind en verken subsidieprojecten in Nederland en Europa.

Links

  • Projecten
  • Regelingen
  • Analyses

Suggesties

Heb je ideeën voor nieuwe features of verbeteringen?

Deel je suggestie
© 2025 SubsidieMeesters. Alle rechten voorbehouden.